Parallel Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-25
| Closed | -$2.55K | – | 3502 |
|
2023
Q2 | $2.55K | Hold |
25
| – | – | ﹤0.01% | 2682 |
|
2023
Q1 | $2.27K | Buy |
+25
| New | +$2.27K | ﹤0.01% | 2719 |
|
2022
Q1 | – | Sell |
-3
| Closed | – | – | 3381 |
|
2021
Q4 | $0 | Sell |
3
-83
| -97% | – | ﹤0.01% | 3385 |
|
2021
Q3 | $9K | Buy |
86
+42
| +95% | +$4.4K | ﹤0.01% | 2127 |
|
2021
Q2 | $6K | Sell |
44
-31
| -41% | -$4.23K | ﹤0.01% | 2239 |
|
2021
Q1 | $7K | Buy |
75
+68
| +971% | +$6.35K | ﹤0.01% | 2072 |
|
2020
Q4 | $1K | Hold |
7
| – | – | ﹤0.01% | 2502 |
|
2020
Q3 | $1K | Sell |
7
-6
| -46% | -$857 | ﹤0.01% | 2502 |
|
2020
Q2 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 2254 |
|